Comparison

Etalocib

Item no. DCC-DC40870-1g
Manufacturer DCChemicals
CASRN 161172-51-6
Amount 1 g
Quantity options 100 mg 1 g 250 mg
Category
Type Inhibitors
Applications other
Specific against other
Purity 0,98
Smiles FC1C([H])=C([H])C(=C([H])C=1[H])C1=C(C([H])=C(C(=C1[H])C([H])([H])C([H])([H])[H])OC([H])([H])C([H])([H])C([H])([H])OC1C([H])=C([H])C([H])=C(C=1C([H])([H])C([H])([H])C([H])([H])[H])OC1=C([H])C([H])=C([H])C([H])=C1C(=O)O[H])O[H]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Manufacturer - Applications
Etalocib (LY293111), an orally active leukotriene B4 receptor antagonist, inhibits the binding of [3H]LTB4, with a Ki of 25 nM. Etalocib (LY293111) prevents LTB4-induced calcium mobilization with an lC50 of 20 nM. Etalocib (LY293111) induces apoptosis.
Molecular Weight
544, 6099

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 g
Available: In stock
available

Delivery expected until 2/26/2026 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close